Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

0 avis

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

Archive ouverte

Edité par CCSD ; Springer Verlag -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors

Archive ouverte | Cochet, Alexandre | CCSD

International audience

HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy

Archive ouverte | Humbert, Olivier | CCSD

International audience

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

Archive ouverte | Berriolo-Riedinger, Alina | CCSD

International audience. To evaluate, in breast cancer patients treated by neoadjuvant chemotherapy, the predictive value of reduction in FDG uptake with regard to complete pathological response (pCR).

Chargement des enrichissements...